Xiuning Le, MD, PhD

Articles by Xiuning Le, MD, PhD

SOHO-02 Trial Investigates BAY 2927088 as Frontline Treatment for HER2-Positive NSCLC

Xiuning Le, MD, PhDNon-Small Cell Lung Cancer | July 7, 2025

Xiuning Le, MD, PhD, discusses the phase 3 trial, which follows the SOHO-01 trial of the oral TKI.

SOHO-01 and FURTHER: Dr. Xiuning Le Discusses IASLC Presidential Symposium Presentations

Xiuning Le, MD, PhDWCLC 2024 | February 28, 2025

The studies were highlighted as plenary presentations during a Presidential Symposium at WCLC 2024.